Aptamer-Conjugated Nanoparticles for Selective Collection and Detection of Cancer Cells
Top Cited Papers
- 24 March 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 78 (9), 2918-2924
- https://doi.org/10.1021/ac052015r
Abstract
We have developed a method for the rapid collection and detection of leukemia cells using a novel two-nanoparticle assay with aptamers as the molecular recognition element. An aptamer sequence was selected using a cell-based SELEX strategy in our laboratory for CCRF-CEM acute leukemia cells that, when applied in this method, allows for specific recognition of the cells from complex mixtures including whole blood samples. Aptamer-modified magnetic nanoparticles were used for target cell extraction, while aptamer-modified fluorescent nanoparticles were simultaneously added for sensitive cell detection. Combining two types of nanoparticles allows for rapid, selective, and sensitive detection not possible by using either particle alone. Fluorescent nanoparticles amplify the signal intensity corresponding to a single aptamer binding event, resulting in improved sensitivity over methods using individual dye-labeled probes. In addition, aptamer-modified magnetic nanoparticles allow for rapid extraction of target cells not possible with other separation methods. Fluorescent imaging and flow cytometry were used for cellular detection to demonstrate the potential application of this method for medical diagnostics.Keywords
This publication has 18 references indexed in Scilit:
- Analytical applications of aptamersBiosensors and Bioelectronics, 2005
- Nanoparticle-Aptamer BioconjugatesCancer Research, 2004
- Aptamer-Based Sensor Arrays for the Detection and Quantitation of ProteinsAnalytical Chemistry, 2004
- Flow cytometric analysis of cell‐surface and intracellular antigens in the diagnosis of acute leukemiaAmerican Journal of Hematology, 2001
- Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification ofp53 and K-ras genes in patients with colorectal cancerInternational Journal of Cancer, 2000
- Aptamers as therapeutic and diagnostic agentsReviews in Molecular Biotechnology, 2000
- Clinical Significance of Cytogenetic Abnormalities in Adult Acute Lymphoblastic LeukemiaBlood, 1998
- Aptamers as therapeutic and diagnostic reagents: problems and prospectsCurrent Opinion in Chemical Biology, 1997
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990